103 related articles for article (PubMed ID: 3530504)
21. Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type III pneumococcal polysaccharide.
McCoy KL; Baker PJ; Stashak PW; Chused TM
J Immunol; 1985 Oct; 135(4):2438-42. PubMed ID: 3875654
[TBL] [Abstract][Full Text] [Related]
22. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
Speirs RS; Benson RW; Knowles BJ; Roberts D
J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
[TBL] [Abstract][Full Text] [Related]
23. Analysis of carrageenan-induced suppression of antibody response.
Vijayakumar RK; Muthukkaruppan VR
Immunology; 1990 Jun; 70(2):181-5. PubMed ID: 2142673
[TBL] [Abstract][Full Text] [Related]
24. In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.
Nencioni L; Villa L; Tagliabue A; Antoni G; Presentini R; Perin F; Silvestri S; Boraschi D
J Immunol; 1987 Aug; 139(3):800-4. PubMed ID: 2955051
[TBL] [Abstract][Full Text] [Related]
25. Amphoteric Mannan as an Immune Response Modifier. New Model Immunobiologically Active
Paulovičová E; Paulovičová L; Čížová A; Mečárová J; Vrzoňová R; Farkaš P; Bystrický S
Immunol Invest; 2023 Nov; 52(4):415-438. PubMed ID: 36975044
[TBL] [Abstract][Full Text] [Related]
26. Differences in the regulation of humoral responses between mice infected with Trypanosoma cruzi and mice administered T. cruzi-induced suppressor substance.
Cunningham DS; Benavides GR; Kuhn RE
J Immunol; 1980 Nov; 125(5):2317-21. PubMed ID: 6776190
[TBL] [Abstract][Full Text] [Related]
27. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro.
Podzorski RP; Gray GR; Nelson RD
J Immunol; 1990 Jan; 144(2):707-16. PubMed ID: 2153174
[TBL] [Abstract][Full Text] [Related]
28. Suppression and enhancement of the T cell-dependent production of antibody to SRBC in vitro by bacterial lipopolysaccharide.
Hoffmann MK; Weiss O; Koenig S; Hirst JA; Oettgen HF
J Immunol; 1975 Feb; 114(2 pt 2):738-41. PubMed ID: 1089715
[TBL] [Abstract][Full Text] [Related]
29. An endotoxin induced serum factor that causes enhancement of antibody response to heterologous erythrocytes.
Tanabe MJ; Tsurumi Y; Nakano M
Microbiol Immunol; 1977 Nov; 21(11):653-65. PubMed ID: 342876
[TBL] [Abstract][Full Text] [Related]
30. Hypolipidemic Effect of Mannan in Mice with Acute Lipemia Induced by Poloxamer 407.
Goncharova NV; Khrapova MV; Pupyshev AB; Korolenko ET; Nešéáková Z; Korolenko TA
Bull Exp Biol Med; 2016 Nov; 162(1):18-22. PubMed ID: 27878733
[TBL] [Abstract][Full Text] [Related]
31. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide I. Comparison of the suppression induced by con A and low dose paralysis.
Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
J Immunol; 1977 Mar; 118(3):952-6. PubMed ID: 15032
[TBL] [Abstract][Full Text] [Related]
32. Vasculitis and anaphylactoid shock in mice induced by the polysaccharide fraction secreted into culture supernatants by the fungus Candida metapsilosis.
Tada R; Takano Y; Murakami H; Ishibashi K; Nagi-Miura N; Adachi Y; Ohno N
Microbiol Immunol; 2011 May; 55(5):357-65. PubMed ID: 21362025
[TBL] [Abstract][Full Text] [Related]
33. Transmission of hapten-specific tolerance to an unrelated carrier.
Zöller M; Andrighetto G
Cell Immunol; 1987 Dec; 110(2):400-12. PubMed ID: 2446781
[TBL] [Abstract][Full Text] [Related]
34. The mannan of Candida albicans lacking β-1,2-linked oligomannosides increases the production of inflammatory cytokines by dendritic cells.
Ueno K; Okawara A; Yamagoe S; Naka T; Umeyama T; Utena-Abe Y; Tarumoto N; Niimi M; Ohno H; Doe M; Fujiwara N; Kinjo Y; Miyazaki Y
Med Mycol; 2013 May; 51(4):385-95. PubMed ID: 23101887
[TBL] [Abstract][Full Text] [Related]
35. Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split products.
Meister H; Heymer B; Schäfer H; Haferkamp O
J Infect Dis; 1977 Feb; 135(2):224-34. PubMed ID: 320273
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.
Jones JM; Amsbaugh DF; Prescott B
J Immunol; 1976 Jan; 116(1):41-51. PubMed ID: 1445
[TBL] [Abstract][Full Text] [Related]
37. Direct activation of human B lymphocytes by Candida albicans-derived mannan antigen.
Mangeney M; Fischer A; Le Deist F; Latgé JP; Durandy A
Cell Immunol; 1989 Sep; 122(2):329-37. PubMed ID: 2475258
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive effects induced by the polysaccharide moiety of some bacterial lipopolysaccharides.
Hasløv K; Fomsgaard A; Takayama K; Fomsgaard JS; Ibsen P; Fauntleroy MB; Stashak PW; Taylor CE; Baker PJ
Immunobiology; 1992 Nov; 186(5):378-93. PubMed ID: 1286878
[TBL] [Abstract][Full Text] [Related]
39. Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro.
Maisch PA; Calderone RA
Infect Immun; 1981 Apr; 32(1):92-7. PubMed ID: 6260688
[TBL] [Abstract][Full Text] [Related]
40. [Adherence of Candida albicans is inhibited by yeast mannan].
Iwamoto L; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
Yakugaku Zasshi; 2006 Mar; 126(3):167-72. PubMed ID: 16508240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
